BridgeBio Pharma Inc (BBIO) USD0.001
2.74%- This stock can be held in a
Stocks and Shares ISASell:$35.92
Buy:$35.95
Change:
$0.60
(1.70%)
$0.60
(1.70%)Market closed | Prices delayed by at least 15 minutes
Sell:$35.92
Buy:$35.95
Change:$0.60
(1.70%)
$0.60
(1.70%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 April 2025 | Andrea EllisDirector | Sell Option/Award related | 10,000 | $35.00 | $350,000.00 | 12,000 |
| 1 April 2025 | Andrea EllisDirector | Sell Option/Award related | 30,000 | $34.05 | $1,021,500.00 | 12,000 |
| 25 March 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 75,000 | $36.87 | $2,764,942.50 | 4,948,447 |
| 6 March 2025 | Hannah ValantineIndependent Director | Sell Option/Award related | 12,875 | $32.58 | $419,499.69 | 1,764 |
| 5 March 2025 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 6,000,000 | $32.96 | $197,760,000.00 | 19,260,971 |
| 25 February 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 37,899 | $33.36 | $1,264,447.08 | 5,060,548 |
| 25 February 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 37,101 | $33.79 | $1,253,524.07 | 5,023,447 |
| 25 February 2025 | Brian C StephensonCFO | Sell Option/Award related | 8,400 | $33.18 | $278,696.88 | 102,564 |
| 25 February 2025 | Brian C StephensonCFO | Sell Option/Award related | 100 | $34.18 | $3,418.00 | 102,464 |
| 19 February 2025 | Neil KumarCEO | Sell Option/Award related | 31,467 | $36.14 | $1,137,245.70 | 211,794 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 5 March 2025 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 6,000,000 | $32.96 | $197,760,000.00 | 19,260,971 |
| 13 September 2024 | KKR GENETIC DISORDER LPInvestment Management Company | Sell Regular sell transaction (market) | 5,800,000 | $25.75 | $149,350,000.00 | 25,260,971 |
| 31 January 2025 | VIKING GLOBAL INVESTORS LPHedge Fund | Sell Regular sell transaction (market) | 3,065,616 | $34.90 | $106,989,998.40 | 22,055,375 |
| 28 January 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 326,932 | $36.29 | $11,863,381.48 | 5,371,515 |
| 29 January 2025 | Neil KumarCEO | Sell Regular sell transaction (market) | 269,068 | $36.34 | $9,777,984.93 | 5,102,447 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.